Q9UNF1 (MAGD2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 96.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Melanoma-associated antigen D2 Alternative name(s): 11B6 Breast cancer-associated gene 1 protein Short name=BCG-1 Hepatocellular carcinoma-associated protein JCL-1 MAGE-D2 antigen | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 606 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
Ontologies
| Keywords | |
|---|---|
| Coding sequence diversity | Alternative splicing Polymorphism |
| Molecular function | Tumor antigen |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| None. [Check GOA] | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9UNF1-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UNF1-2) The sequence of this isoform differs from the canonical sequence as follows: 45-62: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.9 | ||||||
| Chain | 2 – 606 | 605 | Melanoma-associated antigen D2 | PRO_0000156727 | |||||
Regions | |||||||||
| Domain | 279 – 478 | 200 | MAGE | ||||||
| Compositional bias | 215 – 258 | 44 | Arg-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylserine Ref.9 | ||||||
| Modified residue | 2 | 1 | Phosphoserine Ref.20 Ref.21 | ||||||
| Modified residue | 5 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 70 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 72 | 1 | Phosphothreonine Ref.16 Ref.18 | ||||||
| Modified residue | 146 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 157 | 1 | Phosphoserine Ref.12 Ref.19 | ||||||
| Modified residue | 162 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 190 | 1 | Phosphoserine Ref.13 Ref.15 Ref.17 Ref.19 Ref.20 Ref.21 | ||||||
| Modified residue | 191 | 1 | Phosphoserine Ref.15 Ref.17 Ref.19 Ref.20 Ref.21 | ||||||
| Modified residue | 194 | 1 | Phosphoserine Ref.15 Ref.17 Ref.19 | ||||||
| Modified residue | 197 | 1 | Phosphoserine Ref.17 Ref.19 | ||||||
| Modified residue | 247 | 1 | Phosphoserine Ref.13 Ref.14 Ref.18 Ref.19 Ref.21 | ||||||
| Modified residue | 264 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 265 | 1 | Phosphoserine Ref.12 Ref.18 Ref.19 | ||||||
Natural variations | |||||||||
| Alternative sequence | 45 – 62 | 18 | Missing in isoform 2. | VSP_008030 | |||||
| Natural variant | 187 | 1 | E → D. Corresponds to variant rs12014977 [ dbSNP | Ensembl ]. | VAR_053508 | |||||
| Natural variant | 266 | 1 | Q → R. Ref.1 | VAR_011639 | |||||
| Natural variant | 458 | 1 | K → Q in a breast cancer sample; somatic mutation. Ref.23 | VAR_036584 | |||||
Experimental info | |||||||||
| Sequence conflict | 73 | 1 | P → S in AAD00728. Ref.3 | ||||||
| Sequence conflict | 377 | 1 | S → C in BAC03896. Ref.5 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of genes overexpressed in freshly isolated breast cancer specimens." Kurt R.A., Urba W.J., Schoof D.D. Breast Cancer Res. Treat. 59:41-48(2000) [PubMed: 10752678] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ARG-266. Tissue: Fetal lung, Mammary cancer and Mammary gland. |
| [2] | "Expression pattern and further characterization of human MAGED2 and identification of rodent orthologues." Langnaese K., Kloos D.U., Wehnert M., Seidel B., Wieacker P. Cytogenet. Cell Genet. 94:233-240(2001) [PubMed: 11856887] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [3] | "Hepatocellular carcinoma associated gene JCL-1." Jin C.L., Wang D.Y., Wan D.F., Gu J.R. Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "Identification of genes which are differentially expressed in hepatocellular carcinoma by SSH method." Dong X.-Y., Chen W.-F. Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 1). |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Placenta. |
| [6] | "The DNA sequence of the human X chromosome." Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C. Bentley D.R.Nature 434:325-337(2005) [PubMed: 15772651] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Lung and Skeletal muscle. |
| [9] | Bienvenut W.V., Waridel P., Quadroni M. Submitted (MAR-2009) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-13; 77-100; 182-203; 220-227; 262-274; 312-323; 386-397 AND 431-446, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [10] | "Isolation of genes which are differentially expressed in prostate cancer cells." Stubbs A.P., Abel P.D., Lalani E.-N., Stamp G.W.H. Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE OF 346-424. Tissue: Prostatic carcinoma. |
| [11] | "A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells." Lucas S., Brasseur F., Boon T. Cancer Res. 59:4100-4103(1999) [PubMed: 10463614] [Abstract] Cited for: NUCLEOTIDE SEQUENCE OF 369-503. Tissue: Testis. |
| [12] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157 AND SER-265, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190 AND SER-247, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-162; SER-190; SER-191 AND SER-194, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [16] | "Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis." Wang B., Malik R., Nigg E.A., Korner R. Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-72, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-191; SER-194 AND SER-197, MASS SPECTROMETRY. Tissue: Platelet. |
| [18] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-72; SER-247 AND SER-265, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-190; SER-191; SER-194; SER-197; SER-247 AND SER-265, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-190 AND SER-191, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [21] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-5; SER-70; SER-190; SER-191; SER-247 AND SER-264, MASS SPECTROMETRY. |
| [22] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [23] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] GLN-458. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF128527 mRNA. Translation: AAD33392.1. AF128528 mRNA. Translation: AAD33393.1. AF126181 mRNA. Translation: AAD28598.1. AJ293618 mRNA. Translation: CAC19410.1. U92544 mRNA. Translation: AAD00728.1. AF320070 mRNA. Translation: AAG35066.2. AK092463 mRNA. Translation: BAC03896.1. Z98046 Genomic DNA. Translation: CAB10841.1. CH471154 Genomic DNA. Translation: EAW93189.1. BC000304 mRNA. Translation: AAH00304.1. BC091503 mRNA. Translation: AAH91503.1. AF148815 mRNA. Translation: AAF73137.1. AF320907 mRNA. Translation: AAG38603.1. |
| IPI | IPI00009542. IPI00337823. |
| RefSeq | NP_055414.2. NM_014599.4. NP_803182.1. NM_177433.1. NP_957516.1. NM_201222.1. |
| UniGene | Hs.522665. |
3D structure databases | |
| ProteinModelPortal | Q9UNF1. |
| SMR | Q9UNF1. Positions 273-486. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9UNF1. 3 interactions. |
| MINT | MINT-1389350. |
| STRING | Q9UNF1. |
PTM databases | |
| PhosphoSite | Q9UNF1. |
Polymorphism databases | |
| DMDM | 17380153. |
Proteomic databases | |
| PRIDE | Q9UNF1. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000218439; ENSP00000218439; ENSG00000102316. ENST00000375053; ENSP00000364193; ENSG00000102316. ENST00000375058; ENSP00000364198; ENSG00000102316. ENST00000375068; ENSP00000364209; ENSG00000102316. ENST00000396224; ENSP00000379526; ENSG00000102316. |
| GeneID | 10916. |
| KEGG | hsa:10916. |
| UCSC | uc004dtk.1. human. |
Organism-specific databases | |
| CTD | 10916. |
| GeneCards | GC0XP054850. |
| H-InvDB | HIX0023486. |
| HGNC | HGNC:16353. MAGED2. |
| HPA | HPA031572. HPA031573. |
| MIM | 300470. gene. |
| neXtProt | NX_Q9UNF1. |
| PharmGKB | PA30560. |
| GenAtlas | Search... |
Phylogenomic databases | |
| GeneTree | ENSGT00560000076930. |
| HOVERGEN | HBG003714. |
| InParanoid | Q9UNF1. |
| OMA | IKEYTDV. |
| OrthoDB | EOG4R23V1. |
| PhylomeDB | Q9UNF1. |
Gene expression databases | |
| ArrayExpress | Q9UNF1. |
| Bgee | Q9UNF1. |
| CleanEx | HS_MAGED2. |
| Genevestigator | Q9UNF1. |
| GermOnline | ENSG00000102316. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR002190. MAGE. [Graphical view] |
| PANTHER | PTHR11736. MAGE. 1 hit. |
| Pfam | PF01454. MAGE. 1 hit. [Graphical view] |
| PROSITE | PS50838. MAGE. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 41463. |
| SOURCE | Search... |
Entry information
| Entry name | MAGD2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UNF1 Secondary accession number(s): A6NMX0 Q9UM52 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome X Human chromosome X: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with